Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
Abstract Epithelial ovarian cancer (EOC) remains the most lethal gynecological cancer in developed countries, indicating the need for further research. Although current cancer models prove useful, they have major limitations. Organoids, a novel in vitro 3D cell culture technique, derived from stem c...
Main Authors: | Sander Dumont, Ziga Jan, Ruben Heremans, Toon Van Gorp, Ignace Vergote, Dirk Timmerman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13048-019-0577-2 |
Similar Items
-
Glioblastoma organoid technology: an emerging preclinical models for drug discovery
by: Don Carlo Ramos Batara, et al.
Published: (2022-02-01) -
Development of glioblastoma organoids and their applications in personalized therapy
by: Can Xu, et al.
Published: (2023-05-01) -
Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials
by: Tomohiko Ishikawa, et al.
Published: (2023-05-01) -
Organoids in high-throughput and high-content screenings
by: Franziska L. Lampart, et al.
Published: (2023-03-01) -
Ovarian cancer and the immune system
by: Thaïs Baert, et al.
Published: (2017-02-01)